Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-03

Clinical Trial Update: A Study of LY2608204 in Patients With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for LY2608204 in patients with Type 2 diabetes; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY2608204 (LY2608204)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2018-10-03